Showing results (321-330 of 571) with videos related to
Sort By:
Pageof 58
International Journal of Radiation Oncology, Biology, Physics|December 18, 2018
The Insurance Approval Process for Proton Radiation Therapy: A Significant Barrier to Patient CareMatthew S Ning, Daniel R Gomez, Aashish K Shah, et al.Frontiers in Microbiology|April 1, 2026
Autophagy is essential for anti-Wolbachia drug efficacy in Brugia malayi and insect cellsAnfal Yousef, Ellen K G Masters, Yang Wu, et al.Journal of Korean Medical Science|June 29, 2007
The KIDSCREEN-52 quality of life measure for children and adolescents (KIDSCREEN-52-HRQOL): reliability and validity of the Korean versionSungdo David Hong, Jae Won Yang, Won Seok Jang, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 14, 2007
A case-control association study of the polymorphism at the promoter region of the DRD4 gene in Korean boys with attention deficit-hyperactivity disorder: evidence of association with the -521 C/T SNPJae-Won Yang, Won-Seok Jang, Sungdo David Hong, et al.Cancer|August 26, 2010
Phase 1 clinical trials in 83 patients with pancreatic cancer: The M. D. Anderson Cancer Center experienceChristos Vaklavas, Apostolia-Maria Tsimberidou, Sijin Wen, et al.Cancer Treatment Reviews|May 7, 2018
Untying the gordion knot of targeting MET in cancerKanwal Raghav, Ann Marie Bailey, Jonathan M Loree, et al.Scientific Reports|October 18, 2016
Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved TherapiesVivek Subbiah, Kenneth R Hess, Muhammad Rizwan Khawaja, et al.Clinical Breast Cancer|July 29, 2014
Analysis of MET genetic aberrations in patients with breast cancer at MD Anderson Phase I unitDebora de Melo Gagliato, Denis L Fontes Jardim, Gerald Falchook, et al.Brachytherapy|July 20, 2020
Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapyDavid Boyce-Fappiano, Tharakeswara K Bathala, Rong Ye, et al.JCI Insight|June 22, 2023
Nanoparticle-enhanced proton beam immunoradiotherapy drives immune activation and durable tumor rejectionYun Hu, Sébastien Paris, Narayan Sahoo, et al.Pageof 58